Cargando…
Paving the Road for Mesenchymal Stem Cell-Derived Exosome Therapy in Bronchopulmonary Dysplasia and Pulmonary Hypertension
Bronchopulmonary dysplasia (BPD) is a chronic neonatal lung disease characterized by inflammation and arrest of alveolarization. Its common sequela, pulmonary hypertension (PH), presents with elevated pulmonary vascular resistance associated with remodeling of the pulmonary arterioles. Despite notab...
Autores principales: | Yeung, Vincent, Willis, Gareth R., Taglauer, Elizabeth, Mitsialis, S. Alex, Kourembanas, Stella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122497/ http://dx.doi.org/10.1007/978-3-030-29403-8_8 |
Ejemplares similares
-
Mesenchymal stem cell-mediated reversal of bronchopulmonary dysplasia and associated pulmonary hypertension
por: Hansmann, Georg, et al.
Publicado: (2012) -
Macrophage Immunomodulation: The Gatekeeper for Mesenchymal Stem Cell Derived-Exosomes in Pulmonary Arterial Hypertension?
por: Willis, Gareth R., et al.
Publicado: (2018) -
Pulmonary hypertension in bronchopulmonary dysplasia
por: Hansmann, Georg, et al.
Publicado: (2020) -
Toward Exosome-Based Therapeutics: Isolation, Heterogeneity, and Fit-for-Purpose Potency
por: Willis, Gareth R., et al.
Publicado: (2017) -
‘Good things come in small packages’: Application of exosome-based therapeutics in neonatal lung injury
por: Willis, Gareth R, et al.
Publicado: (2017)